Related Experiment Video
Updated: Jun 9, 2025
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
Humans: An integrative review exploring dehumanisation in advanced dementia
Jesper Bøgmose1, Benjamin Miguel Olivares Bøgeskov1, Tom Dening2
1University College Copenhagen.
Nursing Ethics
|October 24, 2024
Summary
Formal caregivers
Area of Science:
- Gerontology
- Ethics in Medicine
- Sociology of Health and Illness
Background:
- Advanced dementia can lead to perceptions of lost personhood, a concept explored in dementia scholarship.
- Existential dehumanisation in dementia care negatively impacts ethical practices and the quality of care.
- Recognising factors that foster dehumanisation is crucial for improving dementia care.
Purpose of the Study:
- To identify perceptions of care recipients with advanced dementia that elicit dehumanising attitudes in formal caregivers.
- To challenge the dehumanisation of individuals with advanced dementia within care settings.
- To inform strategies for enhancing ethical dementia care practices.
Main Methods:
- An integrative review was conducted using Whittemore and Knafl's methodology.
- Analysis included 26 articles encompassing qualitative, quantitative, theoretical, and grey literature.
- The review focused on perceptions of care recipients with advanced dementia leading to dehumanisation.
Main Results:
- Five themes emerged that can foster dehumanising attitudes: perceiving individuals as absurd, shadow, perilous, void, or repugnant.
- These perceptions are argued to stem from unintentional, misled embodied perceptions by caregivers.
- Caregivers need to recognise and resist these embodied perceptions.
Conclusions:
- Challenging dehumanisation in dementia care requires timely identification and reaction to misled embodied perceptions.
- The five identified themes can serve as a warning for caregivers about potential dehumanising attitudes.
- This study aids caregivers in ethically reviewing their perceptions of individuals with advanced dementia.
Related Concept Videos
01:26Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
01:30Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
01:29Documentation in Long-Term and Home Healthcare Setting
873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
873
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:21Kubler Ross's Stages of Dying
61
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
61
00:57Deindividuation
26.3K
Deindividuation is a form of social influence on an individual’s behavior such that the individual engages in unusual or non-normal behavior while in a group setting. Why? Because in these group settings, the individual no longer sees themselves as an individual anymore, disinhibiting their behavior and personal restraint.
26.3K